Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio.
Research Institute, Cleveland Clinic, Cleveland, Ohio.
Clin Gastroenterol Hepatol. 2024 Jun;22(6):1323-1325.e3. doi: 10.1016/j.cgh.2023.11.008. Epub 2023 Nov 19.
Since its release in 2022, Chat Generative Pre-Trained Transformer (ChatGPT) became the most rapidly expanding consumer software application in history, and its role in medicine is underscored by its potential to enhance patient education and physician-patient communication. Previous studies in gastroenterology and hepatology have focused primarily on the earlier Generative Pre-Trained Transformer 3 (GPT-3) model, with none investigating ChatGPT's ability to generate supportive references for its responses, or its applicability as a physician educational tool. Our study evaluated the accuracy of the more recent ChatGPT, powered by GPT-4, in addressing frequently asked questions by patients on irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), colonoscopy and colorectal cancer (CRC) screening, questions on CRC screening from a physician perspective, and reference generation and suitability.
自 2022 年发布以来，Chat Generative Pre-Trained Transformer（ChatGPT）成为历史上增长最快的消费类软件应用程序，它在医学中的作用突出体现在它有潜力增强患者教育和医患沟通。以前在胃肠病学和肝脏病学中的研究主要集中在早期的 Generative Pre-Trained Transformer 3（GPT-3）模型上，没有研究调查 ChatGPT 生成支持其回复的参考文献的能力，也没有研究调查其作为医生教育工具的适用性。我们的研究评估了由 GPT-4 提供支持的较新的 ChatGPT 在回答关于肠易激综合征（IBS）、炎症性肠病（IBD）、结肠镜检查和结直肠癌（CRC）筛查、医生视角下的 CRC 筛查问题以及参考生成和适用性方面的准确性。
